AGA-ASGE Clinical Congress of Gastroenterology and Hepatology
January 17-19, 2013
San Diego, CA
Hotel Del Coronado
Visit the conference home page for complete information about the AGA-ASGE 2013 Clinical Congress of Gastroenterology and Hepatology.
Download the conference brochure here.
Hotel and registration information is available here.
Clinical topics and disease states covered at this year’s event will include viral hepatitis, GERD, Crohn’s disease, ulcerative colitis, pancreatitis, cirrhosis, colorectal cancer, biliary strictures, Barrett’s esophagus, celiac disease, eosinophilic esophagitis, gastroparesis, and more.
According to the official conference brochure, clinicians who attend the 2013 AGA-ASGE Clinical Congress of Gastroenterology and Hepatology will be able to:
- Develop an evidence-based approach to eosinophilic esophagitis, esophageal physiologic studies, dilemmas in PPI use and refractory GERD
- Identify state-of-the-art management of inflammatory bowel disease
- Implement recent advances in the management of viral hepatitis, autoimmune hepatitis, cirrhosis and screening of hepatocellular carcinoma
- Distinguish between the various approaches for managing pancreatic cystic lesions, acute pancreatitis and chronic pancreatitis
- Apply the latest screening and surveillance practices for average and high-risk CRC
- Identify the current clinical significance of ongoing research developments of the gastrointestinal microbiome
Highlights of this year’s Congress include:
- Hands-on courses covering “state of the art expert techniques” in upper (esophagus and gastric therapies) and lower (colonic and intestinal therapies) GI endoscopy
- Sessions on refractory GERD and new Barrett’s imaging techniques
- Courses on managing upper GI bleeding, the use of small bowel imaging, and managing celiac disease
- The Don Powell Lecture: “The Gut Microbiome and Its Potential for Research and Discovery,” delivered by Gail A. Hecht, MD, MS, AGAF
- Sessions on “demystifying colorectal hereditary syndromes,” dietary and pharmacologic approaches to managing irritable bowel syndrome (IBS), and optimizing ADR
- Presentations focusing on the assessment and management of patients with irritable bowel disease, including Crohn’s disease and ulcerative colitis
- Sessions on hepatitis B, hepatitis C, and autoimmune hepatitis
- Lectures on pancreatic and biliary disorders, including acute pancreatitis, chronic pancreatitis, and pancreatic cystic lesions
- Breakout sessions covering food allergies, PPI issues, microscopic colitis, biologics and immune modulators, cirrhosis/portal hypertension, and esophageal physiometry testing
Exhibit Hall Hours
Friday, January 18, 2013
Saturday, January 19, 2013